JP Patent

JP2024506385A — Ｇｄｃ－９５４５及びｇｄｃ－００７７を含む併用療法を使用する乳がんの治療

Assigned to Genentech Inc · Expires 2024-02-13 · 2y expired

What this patent protects

局所進行性乳がん又は転移性乳がんを治療するための、ＧＤＣ－９５４５とＧＤＣ－００７７とを含む併用療法が、本明細書において提供される。 【選択図】図１

USPTO Abstract

局所進行性乳がん又は転移性乳がんを治療するための、ＧＤＣ－９５４５とＧＤＣ－００７７とを含む併用療法が、本明細書において提供される。 【選択図】図１

Drugs covered by this patent

Patent Metadata

Patent number
JP2024506385A
Jurisdiction
JP
Classification
—
Expires
2024-02-13
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.